Biological
Tricom clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2003
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tricom is read from its arms, and is right about nine times in ten.
Testing it · 4
- Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT01875250Written as PROSTVAC-F (Fowlpox)/TRICOM
- Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT00450463Written as PROSTVAC-F/ TRICOM
- Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical ProstatectomyCompletedPhase 2National Cancer Institute (NCI)NCT02153918Written as PROSTVAC-V/TRICOM
- Sequential Vaccinations in Prostate Cancer PatientsCompletedPhase 1/2National Cancer Institute (NCI)NCT00060528Written as Recombinant Fowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM)